When ‘good’ cholesterol goes awry: Cross-sectional association of high HDL-C with prevalent sarcopenia in U.S. adults
Journal of Clinical Lipidology · 2025
DOI: 10.1016/j.jacl.2025.06.005 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Rong-Zhen Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics & Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China (Drs Xie, Zhao, Lian…. Hauptthemen laut MEDLINE: Sarcopenia, Cholesterol, HDL. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sarcopenia-the progressive loss of muscle mass and function-is linked to metabolic dysregulation. Although high-density lipoprotein cholesterol (HDL-C) is usually protective, emerging data suggest a "U-shaped" association with adverse outcomes. We examined the relation between HDL-C and sarcopenia and evaluated mediation by neutrophil-to-lymphocyte ratio (NLR) and homeostasis model assessment of insulin resistance (HOMA-IR). METHODS: We analyzed 2167 National Health and Nutrition Examination Survey 2011 to 2014 adults (≥20 years) with complete dual-energy X-ray absorptiometry, grip-strength, and lipid data. Sarcopenia followed European Working Group on Sarcopenia in Older People 2 criteria. Survey-weighted logistic models progressed from age-sex-ethnicity (Model 1) to body mass index (BMI) (Model 2) and full socioeconomic and clinical covariates (Model 3). HDL-C was treated continuously and as 5 bands ( 70 mg/dL). Bias-corrected bootstrap mediation tested indirect effects via NLR and HOMA-IR. RESULTS: HDL-C was positively associated with sarcopenia in univariate analysis, but the relation disappeared after full adjustment; adding BMI reduced the coefficient by 23%. HDL-C > 70 mg/dL (n = 327) independently predicted sarcopenia (odds ratio: 1.04 per 1 mg/dL, 95% CI, 1.00-1.08). Lower strata were non-significant. NLR showed no mediation. HOMA-IR exerted a small, negative indirect effect (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics & Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China (Drs Xie, Zhao, Liang, Hua, and Huang); Zhejiang Chinese Medical University, Hangzhou, Zhe…
- Department of Orthopaedics and Traumatology, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong, China (Dr Li).
- Department of Orthopaedics & Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China (Drs Xie, Zhao, Liang, Hua, and Huang).
Zitieren
APA
Xie, R. Z., Li, X. S., Zhao, W. Q., Liang, Y. F., Hua, J., & Huang, J. F. (2025). When ‘good’ cholesterol goes awry: Cross-sectional association of high HDL-C with prevalent sarcopenia in U.S. adults. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.06.005
Vancouver
Xie RZ, Li XS, Zhao WQ, Liang YF, Hua J, Huang JF. When ‘good’ cholesterol goes awry: Cross-sectional association of high HDL-C with prevalent sarcopenia in U.S. adults. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.06.005
BibTeX
@article{Xie2025,
author = {Xie, Rong-Zhen and Li, Xu-Song and Zhao, Wei-Qiang and Liang, Yu-Feng and Hua, Jiang and Huang, Jie-Feng},
title = {When ‘good’ cholesterol goes awry: Cross-sectional association of high HDL-C with prevalent sarcopenia in U.S. adults},
journal = {Journal of Clinical Lipidology},
year = {2025},
doi = {10.1016/j.jacl.2025.06.005}
}
EUVIMED